Feiyanning formula modulates the molecular mechanism of osimertinib resistance in lung cancer by regulating the Wnt/β-catenin pathway

• Auteurs principaux: Shuliu Sang (Auteur), Chenbing Sun (Auteur), Rongzhen Ding (Auteur), Jingjie Jiang (Auteur), Yang Han (Auteur), Shanshan Gan (Auteur), Ling Bi (Auteur), Yabin Gong (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Feiyanning Formula (FYN), a Chinese herbal formula derived from summarized clinical experience, is proven to have anti-tumor effects in lung cancer patients. Osimertinib, a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), can improve progression-free survival a...